Viela Bio to Webcast First Quarter 2020 Financial Results and Program Highlights on May 13, 2020

Author's Avatar
May 06, 2020
Article's Main Image

GAITHERSBURG, Md., May 06, 2020 (GLOBE NEWSWIRE) -- Viela Bio (VIE, Financial), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, May 13, 2020 at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights.

The webcast will be accessible on the Events & Presentations page of the Company’s website. Individuals can participate in the conference call by dialing (877) 783-8848 (domestic) or (631) 350-0960 (international) and referring to conference ID #: 3052446. The archived webcast will be available for replay on the Viela Bio website approximately two hours after the event.

About Viela Bio

Viela Bio, headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.

Source: Viela Bio

Contacts:

Investors:
Solebury Trout
Chad Rubin
646-378-2947
[email protected]

Media:
Solebury Trout
Amy Bonanno
914-450-0349
[email protected]

ti?nf=NzkxNTQ4NSMzNDk2MjIwIzIxODgwMjY=